Common medication side effects Flashcards
Ladder of severity of dystonias from typical antipsychotics
Torticollis: Unilateral neck pain and restriction of motion
Oculogyric crisis: Sustained upwards deviation of eyes and clenched jaw with hyperextension of back/neck
Neuroleptic malignant syndrome: Medical emergency. Altered mental state, rigidity, fever, fluctuating BP and high temperature.
Chronic dystonia from typical antipsychotics
Tardive dyskinesia occurs in patients on long term typical antipsychotics. uncontrolled facial movement and lip-smacking.
Akathisia is also a chronic symptom of restlessness in patients on long term antipsychotics
Antipsychotics receptor of action
D2 dopamine: blocks mesolimbic pathways.
EPSEs are common: dystonia, parkinsonism, akathisia, tardive dyskinesia- can be managed with procyclidine.
Increased risk of stroke and VTE
Common side effect profile of Antipsychotics
Anti-muscarinic side effects; dry mouth, blurred vision, urinary retention.
Occasionally proactinaemia: galactorrhoea - inhibition of the dopaminergic tuberinfundibular pathway
Impaired glucose tollerance.
More sevrely - Neuroleptic malignant syndrome, seizures and QT prolongation
Acute interstitial nephritis presentation
Triad of rash, fever, eosinophilia. Typically with Beta lactams. Typically occurs with the initiation of the drug
Vasculitis post medication use timeline
typically 7 -10 days
Nitrofurantoin
Lung fibrosis
Management of oculogyric crisis
Benztropine or procyclidine
Causes of raised anion gap metabolic acidosis
CAT MUDPILE
Carbon monoxide, cyanoide, caffeine, aceaminophen and aspirin, theophyline
Methanol, metformin Uraemia DKA Propylene glycol Isoniazid, ibuprofen, iron Lactic acidosis Ethylene glycol
Causes of normal anion gap metabolic acidosis
ABCD: Addisons, Bicarb loss (GI, Renal including RTA), Chloride, Drugs (Acetazolamide, acids)
First line therapy for ethylene glycol toxicity
Fomepizole, otherwise can use ethanol
MOA of Aspirin
non-reversible Cox 1 and 2 inhibitor
MOA of Dipyriudamole
Phosphodiesterase 3 inihibitor : reduces intracellular cAMP and cGMP
Name 2 P2Y12 inihibitors
Clopidogrel and ticagrelor
MOA Abciximab, eptifibatide, tirofiban
GP IIa/IIIb inhibitor. Prevent platelets aggregating with fibrinogen